Lifecore Biomedical
LFCR
108 hedge funds and large institutions have $355M invested in Lifecore Biomedical in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 36 reducing their positions, and 6 closing their positions.
150% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 6
9% more funds holding
Funds holding: 99 → 108 (+9)
4% more capital invested
Capital invested by funds: $342M → $355M (+$13.8M)
17% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 36
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$6.21M |
| 2 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$3.14M |
| 3 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$2.91M |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
+$2.55M |
| 5 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$1.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$8.86M |
| 2 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
-$5.38M |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
-$4.92M |
| 4 |
Morgan Stanley
New York
|
-$2.39M |
| 5 |
KG
Killen Group
Berwyn,
Pennsylvania
|
-$971K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
BlackRock
New York
| $10K | – | – | – |
|
102
US Bancorp
Minneapolis,
Minnesota
| $9K | – | – | – |
|
103
Zurich Cantonal Bank
Zurich,
Switzerland
| $9K | – | – | – |
|
104
Citigroup
New York
| $8K | -$17.5K | -1,211 | -68% |
|
|
HR
105
Howe & Rusling
Rochester,
New York
| $4K | – | – | – |
|
|
TCOV
106
Trust Company of Vermont
Brattleboro,
Vermont
| $4K | +$4.33K | +300 | New |
|
107
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $3K | +$1.33K | +92 | +83% |
|
108
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $265 | +$505 | +35 | +0.2% |
|
|
BMCMI
109
Bryn Mawr Capital Management Inc
Bryn Mawr,
Pennsylvania
| – | -$280K | -20,046 | Closed |
|
110
Renaissance Technologies
New York
| – | -$197K | -14,100 | Closed |
|
111
LSV Asset Management
Chicago,
Illinois
| – | -$115K | -8,300 | Closed |
|
112
AllianceBernstein
Nashville,
Tennessee
| – | -$81K | -5,800 | Closed |
|
113
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$7K | -526 | Closed |
|
114
Creative Planning
Overland Park,
Kansas
| – | -$1K | -100 | Closed |
|
LFCR Hedge Fund Activity: Q2 2015 in Review
108 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q2 2015, worth a combined $355M — up 4% from $342M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new LFCR positions and 6 closed out — a net gain of 9 holders — while 30 added to existing stakes and 36 trimmed.
The largest buyer was Heartland Advisors, adding an estimated $6.21M. The largest seller was Guggenheim Capital, cutting an estimated $8.86M.
- 108 institutional investors held Lifecore Biomedical (LFCR) as of Q2 2015, up from 99 in Q1 2015.
- Funds reported $355M of Lifecore Biomedical stock for Q2 2015, up 4% quarter-over-quarter.
- 15 funds opened new Lifecore Biomedical positions in Q2 2015 and 6 closed out, a net change of +9 holders.
- The largest Lifecore Biomedical buyer in Q2 2015 was Heartland Advisors, an estimated $6.21M added.
- The largest Lifecore Biomedical seller in Q2 2015 was Guggenheim Capital, an estimated $8.86M sold.
Based on aggregated 13F filings for Q2 2015.